[The efficacy of heparin therapy in patients with diabetic glomerulosclerosis]

Heparin therapy (25,000 U/day) of 38 patients with diabetic glomerulosclerosis resulted in improvement in 31 (82 +/- 6%). The treatment was not effective in 5% and complications were seen in 2 patients. Blood coagulation control is necessary during heparin treatment and turbidimetry proved to be highly informative in objective registration of coagulation and fibrinolysis processes.